Michelle Cuccia
Vertrieb & Marketing bei ENZYMOTEC LTD.
Profil
Michelle Cuccia is currently the Chief Executive Officer at VAYA Pharma, Inc. and Vice President-Marketing at Enzymotec Ltd.
She previously worked as Vice President-Marketing at Teva Pharmaceutical Industries Ltd.
Ms. Cuccia has a graduate degree from The Trustees of Columbia University in The City of New York and an undergraduate degree from Cornell University.
Aktive Positionen von Michelle Cuccia
Unternehmen | Position | Beginn |
---|---|---|
ENZYMOTEC LTD. | Vertrieb & Marketing | 01.08.2017 |
VAYA Pharma, Inc.
VAYA Pharma, Inc. Pharmaceuticals: MajorHealth Technology Part of International Flavors & Fragrances, Inc., VAYA Pharma, Inc. engages in the discovery, development, manufacture and marketing of natural lipids based medicines. The company is based in Baltimore, MD. Michelle Cuccia has been the CEO of the company since 2017. | Vorstandsvorsitzender | 01.08.2017 |
Ehemalige bekannte Positionen von Michelle Cuccia
Unternehmen | Position | Ende |
---|---|---|
TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Vertrieb & Marketing | - |
Ausbildung von Michelle Cuccia
The Trustees of Columbia University in The City of New York | Graduate Degree |
Cornell University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Health Technology |
Private Unternehmen | 2 |
---|---|
Enzymotec Ltd.
Enzymotec Ltd. BiotechnologyHealth Technology Enzymotec Ltd. develops and manufactures bio functional ingredients for health needs. The company was founded on March 8, 1998 and is headquartered in Migdal HaEmeq, Israel. | Health Technology |
VAYA Pharma, Inc.
VAYA Pharma, Inc. Pharmaceuticals: MajorHealth Technology Part of International Flavors & Fragrances, Inc., VAYA Pharma, Inc. engages in the discovery, development, manufacture and marketing of natural lipids based medicines. The company is based in Baltimore, MD. Michelle Cuccia has been the CEO of the company since 2017. | Health Technology |